AZ’ roxadustat successful in late-stage trial

25th July 2019 Uncategorised 0

The trial met its primary efficacy endpoint of a mean change in haemoglobin from baseline averaged over weeks 23-27.

More: AZ’ roxadustat successful in late-stage trial
Source: News